Lead Product(s) : Plazomicin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Cipla Launches ZEMDRI (Plazomicin) in India, Aims to Tackle AMR
Details : Zemdri (plazomicin), a novel treatment for complicated Urinary Tract Infections (cUTI), including pyelonephritis is launched in India.
Product Name : Zemdri
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 21, 2025
Lead Product(s) : Plazomicin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Plazomicin
Therapeutic Area : Nephrology
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Plazomicin Study in ESRD Patients Receiving IHD
Details : Plazomicin Sulfate is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Kidney Failure, Chronic.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 07, 2021
Lead Product(s) : Plazomicin
Therapeutic Area : Nephrology
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Plazomicin
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Assess the Effect of Plazomicin on the Pharmacokinetics of Metformin
Details : Plazomicin is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 01, 2017
Lead Product(s) : Plazomicin
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Plazomicin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Plazomicin is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Urinary Tract Infections.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 01, 2015
Lead Product(s) : Plazomicin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Plazomicin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Department of Health and Human Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Plazomicin is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Sepsis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 28, 2013
Lead Product(s) : Plazomicin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Department of Health and Human Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Plazomicin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Plazomicin is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Urinary Tract Infections.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 31, 2010
Lead Product(s) : Plazomicin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
